Libra Infusions Limited announced unaudited earnings results for the second quarter and six months ended December 31, 2016. The company's EPS was BDT 4.74 for October-December, 2016 as against BDT 8.14 for October-December, 2015. The company's EPS was BDT 0.78 for July-December, 2016 as against BDT 2.69 for July-December, 2015. NOCFPS was BDT 2.28 for July-December, 2016 as against BDT 43.51 for July-December, 2015. NAV per share was BDT 1,576.37 as on December 31, 2016 and BDT 1,575.64 as on December 31, 2015.